https://www.selleckchem.com/pr....oducts/R788(Fostamat
edom from clinically driven target lesion revascularization (cd TLR) was 95 % at 30 days and 75 % at 12 months follow-up. Female sex was an independent predictor for cd TLR at 12 months follow-up. Retrograde use of the Outback™ re-entry catheter in infra-inguinal chronic total occlusions provides an effective and safe endovascular adjunct, when conventional antegrade and retrograde recanalization attempts have failed. Retrograde use of the Outback™ re-entry catheter in infra-inguinal chronic total occlusions provides
Like
Comment
Share
